These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6436029)

  • 1. Effects of fenflumizole on aggregation ex vivo of human platelets and formation of thromboxane B2 and 6-keto-prostaglandin-F1 alpha.
    Vinge E; Corell T; Andersson KE
    Eur J Clin Pharmacol; 1984; 26(6):711-7. PubMed ID: 6436029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of repeated oral doses of fenflumizole on platelet aggregation and thromboxane formation in man ex vivo.
    Dahl-Puustinen ML; Corell T; Koch K; Puustinen T
    Prostaglandins Leukot Essent Fatty Acids; 1988 Feb; 31(2):101-6. PubMed ID: 3357910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arachidonic acid-induced platelet aggregation and prostanoid formation in whole blood in relation to plasma concentration of indomethacin.
    Vinge E
    Eur J Clin Pharmacol; 1985; 28(2):163-9. PubMed ID: 3921386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenflumizole: interactions with the arachidonic acid cascade.
    Corell T; Hasselmann G; Splawinski J; Wojtaszek B
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):297-303. PubMed ID: 6417973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of fenflumizole on platelet aggregation in patients with unstable angina pectoris.
    Grauholt AM; Grande P; Wadt J
    Eur J Clin Pharmacol; 1987; 31(5):547-51. PubMed ID: 2951260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet effects of fenflumizole, a new anti-inflammatory drug, in dogs.
    Nabata H; Uchino M; Okazaki A; Sakai K
    Jpn J Pharmacol; 1987 May; 44(1):97-100. PubMed ID: 3626187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single intravenous and oral doses of fenflumizole: pharmacokinetics and effects on prostanoid formation.
    Vinge E; Arnold E; Rasmussen SN; Midskov C
    Acta Pharmacol Toxicol (Copenh); 1985 Aug; 57(2):121-9. PubMed ID: 3840639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprotinin decreases release of 6-keto-prostaglandin F1 alpha and increases release of thromboxane B2 in cultured human umbilical vein endothelial cells.
    Havel MP; Griesmacher A; Weigel G; Owen A; Simon P; Müller MM; Wolner E
    J Thorac Cardiovasc Surg; 1992 Sep; 104(3):654-8. PubMed ID: 1381028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat.
    Maguire ED; Wallis RB
    Thromb Res; 1983 Oct; 32(1):15-27. PubMed ID: 6689221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic and ulcerogenic effects of fenflumizole, a new anti-inflammatory imidazole derivative, in rats.
    Nabata H; Uchino M; Okazaki A; Yamazaki T; Sakai K
    Jpn J Pharmacol; 1987 May; 44(1):93-6. PubMed ID: 3114525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.
    Rosenkranz B; Fischer C; Meese CO; Frölich JC
    Br J Clin Pharmacol; 1986 Mar; 21(3):309-17. PubMed ID: 3083851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of fenflumizole on platelet aggregation in man.
    Grande P; Wadt J; Corell T
    Eur J Clin Pharmacol; 1984; 27(2):169-72. PubMed ID: 6437841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nicotine on fetal prostacyclin and thromboxane in humans.
    Ylikorkala O; Viinikka L; Lehtovirta P
    Obstet Gynecol; 1985 Jul; 66(1):102-5. PubMed ID: 3839296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
    Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
    Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ethanol on thromboxane and prostacyclin synthesis by fetal platelets and umbilical artery.
    Ylikorkala O; Halmesmäki E; Viinikka L
    Life Sci; 1987 Jul; 41(3):371-6. PubMed ID: 3110528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of acetaminophen and its analogues on human platelet aggregation and thromboxane B2 synthesis.
    Shorr RI; Kao KJ; Pizzo SV; Rauckman EJ; Rosen GM
    Thromb Res; 1985 Apr; 38(1):33-43. PubMed ID: 3923647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
    Reilly IA; Doran JB; Smith B; FitzGerald GA
    Circulation; 1986 Jun; 73(6):1300-9. PubMed ID: 2938849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane synthetase inhibition as antithrombotic strategy.
    Vermylen J; Defreyn G; Carreras LO; Machin SJ; Van Schaeren J; Verstraete M
    Lancet; 1981 May; 1(8229):1073-5. PubMed ID: 6112447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production.
    Walsh SW
    Am J Obstet Gynecol; 1985 Jun; 152(3):335-40. PubMed ID: 3923838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.